Targeted Lifestyle Change Group Prenatal Care NCT04090307

Clinical Trial Details — Status: Enrolling by invitation

Administrative data
NCT number	NCT04090307
Other study ID #	201901030
Secondary ID
Status	Enrolling by invitation
Phase	N/A
First received
Last updated
Start date	November 26, 2019
Est. completion date	December 2024

Study information
Verified date	May 2024
Source	Washington University School of Medicine
Contact	n/a
Is FDA regulated	No
Health authority
Study type	Interventional

Clinical Trial Summary

To conduct a randomized trial to determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal and neonatal outcomes in women at high risk for developing gestational diabetes mellitus (GDM).

Description:

Long term, the investigator aims to test the central hypothesis that those in TLC will have better maternal and neonatal outcomes than those in TC. The objective is to conduct a randomized trial to determine the effect of TLC group prenatal care on birthweight and neonatal body composition, maternal healthy lifestyle and diabetes-related outcomes, delivery and neonatal outcomes, and psychosocial stress and depression.

Recruitment information / eligibility
Status	Enrolling by invitation
Enrollment	416
Est. completion date	December 2024
Est. primary completion date	June 2024
Accepts healthy volunteers	No
Gender	Female
Age group	13 Years and older
Eligibility	Inclusion Criteria: - English speaking - =16 weeks' gestation - Two or more of the following GDM risk factors: - BMI=25 - Physical inactivity - First degree relative with diabetes - High risk race or ethnicity (African American, Latino, Native American, Asian American, Pacific Islander) - Prior infant weighing = 4,000 g - Prior GDM - Hypertension (140/90 mm Hg or receiving treatment) - High-density lipoprotein cholesterol level <35 mg/dL or triglycerides > 250 mg/dL - Polycystic ovarian syndrome - A1c=5.7% - Impaired glucose tolerance - Impaired fasting glucose on previous testing - History of cardiovascular disease - Ability to attend group prenatal visits at specified days and times - Willingness to be randomized - Ability to give informed consent Exclusion Criteria: - Type 2 diabetes (eligible for Diabetes Group Care) - Positive glucose challenge test during early pregnancy - Multiple gestation (require extra care) - Major fetal anomaly (require extra care) - Serious medical co-morbidity necessitating more care than can be safely provided in group setting, as deemed by medical provider (require extra care) - Serious psychiatric illness, including schizophrenia, necessitating more care than can be safely provided in group setting, as deemed by medical provider (require extra care)

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• TLC Group Prenatal Care
TLC will start in the late first trimester or early second trimester and run for ~6-10 sessions. Groups of 2-10 consented women, with two or more GDM risk factors, will meet under the supervision of an obstetric provider (nurse practitioner or MD) and co-facilitator (health educator, nutritionist, or nurse) for two-hour sessions. A major focus of TLC will be education, and much of each visit will be spent on pregnancy, exercise/nutrition education, and behavioral health.

Locations
Country	Name	City	State
United States	Washington University in St. Louis	Saint Louis	Missouri

Sponsors *(1)*
Lead Sponsor	Collaborator
Washington University School of Medicine

Country where clinical trial is conducted

United States,

Outcome
Type	Measure	Description	Time frame
Primary	Effects of TLC group prenatal care on birth weight	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant weight in grams	Delivery/within 1 week of delivery
Primary	Effects of TLC group prenatal care on neonatal length	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant length in cm	Delivery/within 1 week of delivery
Primary	Effects on TLC group prenatal care on neonatal head circumference	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant head circumference in cm	Delivery/within 1 week of delivery
Primary	Effects of TLC group prenatal care on infant skinfold thickness	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant skinfold thickness of ilium, thigh, triceps, and subscapular	Delivery/within 1 week of delivery
Secondary	Maternal diagnosis of gestational diabetes	Assessing maternal diagnosis of gestational diabetes using 2-step method(1-hour glucose challenge test, 3-hour glucose tolerance test, need for medication)	Up to the time of delivery
Secondary	Physical activity and eating behavior	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on physical activity and eating behavior survey	At enrollment, the last study visit/delivery, and 4-12 weeks postpartum
Secondary	Maternal gestational weight gain	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal gestational weight gain	Initial visit through 4-12 weeks postpartum
Secondary	Maternal hypertensive disorders of pregnancy including gestational hypertension, chronic hypertension, preeclampsia, eclampsia, and HELLP	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal hypertensive disorders of pregnancy	Initial visit through 4-12 weeks postpartum
Secondary	Rates of appointment attendance	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on number of prenatal visits attended	Up to the time of delivery
Secondary	Rates of maternal postpartum visit attendance for those in TLC compared to traditional prenatal care	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on postpartum visit attendance	4-12 weeks postpartum
Secondary	Rate of maternal contraception initiation for those in TLC compared to traditional prenatal care.	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal postpartum contraception initiation	Delivery through 4-12 weeks postpartum
Secondary	Breastfeeding rates among those in TLC compared to traditional prenatal care.	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal breastfeeding	Delivery through 4-12 weeks postpartum
Secondary	Postpartum weight retention	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal postpartum weight retention	Up to 12 weeks postpartum
Secondary	Postpartum 2 hour glucose tolerance testing (if applicable)	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal glucose tolerance testing	4-12 weeks Postpartum
Secondary	Insulin resistance	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal insulin resistance (fasting and 30 min insulin).	Through study completion, up to 12 weeks postpartum
Secondary	Insulin sensitivity	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal insulin sensitivity (fasting and 30 min insulin).	Through study completion, up to 12 weeks postpartum
Secondary	Assessing prenatal care patient satisfaction for those in TLC compared to traditional prenatal care using a satisfaction survey.	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal prenatal care satisfaction	Delivery
Secondary	Neonatal gestational age at delivery	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant gestational age at delivery	Delivery
Secondary	Induction of labor rates for those in TLC compared to traditional prenatal care	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal induction of labor	Delivery
Secondary	Mode of delivery for those in TLC compared to traditional prenatal care.	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC)on maternal mode of delivery	Delivery
Secondary	Neonatal shoulder dystocia rates for those in TLC compared to traditional prenatal care.	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant shoulder dystocia	Delivery
Secondary	Neonatal APGAR score	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant APGAR score	Delivery
Secondary	Neonatal cord blood analytes	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant cord blood analytes, c-peptide.	Delivery
Secondary	Neonatal cord blood analytes of pH for those in TLC compared to traditional prenatal care.	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant cord blood analytes, pH.	Delivery
Secondary	Neonatal cord blood analytes of base excess for those in TLC compared to traditional prenatal care.	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant cord blood analytes, base excess.	Delivery
Secondary	Neonatal NICU admission	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant NICU admission	Delivery
Secondary	Neonatal hypoglycemia	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant hypoglycemia	Delivery
Secondary	Neonatal hematocrit	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant hematocrit	Delivery
Secondary	Neonatal jaundice	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant jaundice	Delivery
Secondary	Neonatal respiratory distress syndrome	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant respiratory distress syndrome	Delivery
Secondary	Neonatal stillbirth	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on infant stillbirth	Delivery
Secondary	Depression	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal depression using Edinburgh Postnatal Depression Scale	Enrollment through 4-12 weeks postpartum
Secondary	Psychosocial stress	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal stress using the perceived stress scale	Enrollment through 4-12 weeks postpartum
Secondary	Determine the effect of TLC on psychosocial stress and depression using the pregnancy distress questionnaire	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal distress	Enrollment through 4-12 weeks postpartum
Secondary	Determine the effect of TLC on psychosocial stress and depression using the life events checklist	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal life events	Enrollment through 4-12 weeks postpartum
Secondary	Determine the effect of TLC on psychosocial stress and depression using the generalized anxiety disorder-7 test	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal anxiety	Enrollment through 4-12 weeks postpartum
Secondary	Determine the effect of TLC on psychosocial stress and depression using the Munich Chronotype Questionnaire (MCTQ)	Determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal sleep hygiene.	Enrollment through 4-12 weeks postpartum

See also
Status	Clinical Trial	Phase
Completed	`NCT03442582` - Afluria Pregnancy Registry
Terminated	`NCT02161861` - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study	N/A
Not yet recruiting	`NCT05934318` - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)	N/A
Enrolling by invitation	`NCT05415371` - Persistent Poverty Counties Pregnant Women With Medicaid	N/A
Completed	`NCT04548102` - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman	N/A
Completed	`NCT03218956` - Protein Requirement During Lactation	N/A
Completed	`NCT02191605` - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy	N/A
Completed	`NCT02223637` - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting	`NCT06049953` - Maternal And Infant Antipsychotic Study
Completed	`NCT02577536` - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting	`NCT06336434` - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy	Phase 1/Phase 2
Not yet recruiting	`NCT05412238` - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months	N/A
Not yet recruiting	`NCT04786587` - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting	`NCT05028387` - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed	`NCT02683005` - Study of Hepatitis C Treatment During Pregnancy	Phase 1
Completed	`NCT02783170` - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women	Phase 4
Recruiting	`NCT02564250` - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women	N/A
Recruiting	`NCT02619188` - Nutritional Markers in Normal and Hyperemesis Pregnancies	N/A
Recruiting	`NCT02507180` - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed	`NCT02528136` - The Clinical Carbetocin Myocardium Trial	Phase 4

Targeted Lifestyle Change Group Prenatal Care

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

Study information

Clinical Trial Summary

Description:

Recruitment information / eligibility

Study Design

Related Conditions & MeSH terms

Intervention

Locations

Sponsors (1)

Country where clinical trial is conducted

Outcome